patient focused News
-
Centric Medical Announces First Clinical Cases With Saturn External Fixation System
Centric Medical, the Foot & Ankle division of Life Spine, Inc., which focuses on developing surgical implants for the treatment of distal extremity pathology announced today the first clinical cases of SATURN External Fixation System. This System is comprised of various rings, struts, pins, bolts, and other fixation components intended to be used as a means to stabilize bone segments for ...
-
Centric Medical Announces Commercial Launch of MTP Plating System
Centric Medical, the Foot & Ankle division of Life Spine, Inc., which focuses on developing surgical implants for the treatment of distal extremity pathology announced today the commercial launch of its MTP Plating System. This System is comprised of various plates, screws and other fixation components intended to stabilize bone segments for indications within the foot and ankle. ...
-
Centric Medical Announces New Release of Sterile-Packed Rogue+™ Hammertoe Correction System Implants
Centric Medical, the Foot & Ankle division of Life Spine, Inc., which focuses on developing surgical implants for the treatment of distal extremity pathology announced today the release of the ROGUE+ Hammertoe Correction System. This sterile-packed innovative system adds to the original implant design also available, while providing internal fixation via a dual threaded construct which is ...
-
CrossBay Medical Receives FDA Clearance for CrossGlide ETS Plus
CrossBay Medical receives FDA Clearance for CrossGlide™ ETS Plus for frictionless, office-based endometrial biopsy procedures focused on patient comfort. Similar to the CrossGlide ETS, Endometrial Tissue Sampler (which received FDA clearance this summer), the ETS Plus also enables medical providers to perform a frictionless, office-based endometrial biopsy procedure gently, effortlessly and ...
-
Caldera Medical Announces FDA Clearance for New Desara TVez for Stress Urinary Incontinence
Caldera Medical, a medical device company that develops best-in-class surgical products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, and Polyps announced the launch of Desara® TVez, an expansion to their Desara® Family of products. “Staying true to our commitment of being surgeon and patient focused, Caldera Medical collaborated with dozens of leading ...
-
Inspiration Healthcare Group PLC New Head Office Opened by Local MP
Inspiration Healthcare Group plc is pleased to announce the opening of its new corporate head office in the Manor Royal Business District, Crawley, UK. The newly redeveloped 4,500 ft2 office in the Satellite Business Village was officially opened on Friday 3rd March 2017 by Henry Smith MP who unveiled a commemorative plaque and joined guests, the Inspiration Healthcare Group plc Board of ...
-
Forest Devices Launches Collaboration with Alberta Health Services
Medical technology pioneer Forest Devices, Inc. (FDI) today announced a commitment to improve healthcare delivery for stroke patients in Alberta, forming a collaboration with Alberta Health Services (AHS) to evaluate and test technologies that can improve patient outcomes and health system performance by empowering emergency first responders to make informed decisions regarding care for stroke ...
-
Outset Medical Launches Inaugural ESG Report
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the release of its inaugural Environmental, Social, and Governance (ESG) report highlighting its ESG-related programs, priorities, goals, and performance. “At Outset, our ESG journey is rooted in our ...
-
Foundation Medicine Appoints Dymeka Harrison as Chief Commercial Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced the appointment of Dymeka Harrison, MBA, as its Chief Commercial Officer. In this role, Harrison will develop and execute global clinical commercial strategy, champion a broader understanding of comprehensive genomic profiling (CGP) and promote Foundation Medicine’s proven portfolio of testing services. ...
-
STRENGTH IN NUMBERS: the Bonnie J. Addario Lung cancer foundation and the Joan Gaeta Lung cancer fund join forces
For more than three years, the Bonnie J. Addario Lung Cancer Foundation in San Francisco and the Joan Gaeta Lung Cancer Fund (formerly Foundation) in Atlanta, have worked tirelessly back and forth across the country in their efforts to eradicate lung cancer. Now, as the Bonnie J. Addario Lung Cancer Foundation (BJALCF) prepares to celebrate its sixth anniversary in 2011, the organizers of the ...
-
Ben Watt Joins SERB and BTG as Group CFO
SERB and BTG Specialty Pharmaceuticals are pleased to announce that Ben Watt has been named the group’s new Chief Financial Officer. Ben is an experienced CFO with a track record of building global finance teams and integrating business acquisitions. Ben most recently served as CFO of Crouzet, an independent manufacturer of electronic components used in heavily regulated industries. He ...
-
Neuspera Announces Leadership Expansion with the Addition of New CFO and CMO
Neuspera Medical, a medical device company developing implantable medical device technology for patients battling chronic illness, today announced the hiring of industry veterans Melissa Farina as Chief Financial Officer and Steven Siegel, MD, as Chief Medical Officer. Farina and Siegel have joined Neuspera as the company recently began enrollment of the second phase of their pivotal clinical ...
-
Thomas Kolaras Joins SERB and BTG Specialty Pharmaceuticals as US Chief Commercial Officer
SERB and BTG Specialty Pharmaceuticals are pleased to announce that Thomas Kolaras has been named the group’s new Chief Commercial Officer for its US business. Thomas is an accomplished commercial leader with more than 25 years of US and global experience across large and mid-sized biopharmaceutical companies. His career includes a wide range of roles in marketing, sales, operations, ...
-
Defymed and GlioCure initiate collaboration in the field of solid tumours without therapeutic options
Defymed, a Strasbourg-based medical technology company, and GlioCure, a neuro-oncology drug development company based in Angers, France, have set themselves the joint goal of exploring a new therapeutic approach for solid tumors that have no therapeutic option or that are resistant to standard treatments due to the overexpression of the TUBB3 protein. TUBB3 is a constitutive molecule of ...
By Defymed
-
SERB acquires the rights to Xermelo outside US and Japan for Carcinoid Syndrome Diarrhoea
SERB is pleased to announce it has acquired the rights from Ipsen to commercialize Xermelo® (telotristat ethyl) in Europe and other countries outside the US and Japan. Financial terms of the transaction were not disclosed. Xermelo is indicated for the treatment of carcinoid syndrome diarrhoea (CSD) in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by ...
-
Kaiser permanente ranked no. 1 on the 2011 diversityinc top 50 companies for diversity(R) list
Kaiser Permanente has been named No. 1 on the 2011 DiversityInc Top 50 Companies for Diversity list, reaching the top spot after first debuting on the publication's list in 2006. "We're particularly proud of this award in recognition of Kaiser Permanente's longstanding effort of promoting diversity and inclusion," said Chairman and Chief Executive Officer George Halvorson. "As an organization, ...
-
Team Gleason Partners with Synchron to Redefine Accessibility
Team Gleason and Synchron, an endovascular brain computer interface company, today announced a partnership agreement to provide patient-focused feedback on their platform to transform daily life for patients with physical and speech disabilities like ALS, muscular dystrophy, and cerebral palsy. The partnership will enable Synchron to collaborate with Team Gleason’s expert committees and an ...
-
Isto Biologics acquires TheraCell, adding additional novel products to help patients heal faster.
Isto Biologics, a leader in surgical-based, orthobiologic regeneration technologies and cell-based therapies, announced today that it has acquired TheraCell, Inc., a California-based regenerative medicine company. The acquisition will strengthen Isto’s focus on offering extraordinary solutions for surgical and clinical care procedures within spine, orthopedics, and sports medicine. ...
-
ALS research gets a $4.1 million boost from CVS/pharmacy fundraising Campaign
In just 21 days, CVS/pharmacy's ninth annual in-store fundraising campaign to support the fight against amyotrophic lateral sclerosis (ALS) brought in $4.1 million. The funds raised by the campaign will be donated to the Boston-based ALS Therapy Alliance (ATA) to support the funding of new clinical research aimed at developing new therapies for ALS patients and focused on the ultimate goal of ...
-
Iterative Scopes Partners with One GI to Advance Gastrointestinal Care Through Artificial Intelligence
Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with One GI®, a gastroenterology management services organization (MSO), to bring its AI Recruitment (AIR) technology to One GI’s clinical research. Initially, One GI® will use AIR at Gastro One, one of One GI’s clinical research sites in Memphis, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you